Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-18

Clinical Trial Update: Clinical Trial of the invisaRED® IR REHAB Device When Used as an Adjunctive Therapy for Nociceptive Musculoskeletal Pain [NA]

View source ↗

Summary

Completed clinical trial evaluating the invisaRED IR REHAB device as an adjunctive therapy for nociceptive musculoskeletal pain; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IR Technology, LLC | Conditions: Nociceptive Pain, Musculoskeletal Pain | NA | Status: COMPLETED | Results posted: 2025-03-18